Biotech

Sernova and JDRF Announce Funding of Joint Research Collaboration to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes

LONDON, ONTARIO: $2.45 Million USD Awarded to Advance Sernova's Cell Pouch System(TM) (CPS) Technologies in a US FDA Clinical Trial With Initiation Scheduled for the Second Half of 2016 ...

Ceapro Inc. Closes an Initial Tranche of a Brokered Private Placement

EDMONTON, ALBERTA: ...

Theravance Biopharma to Present at Cantor Fitzgerald''s 2nd Annual Healthcare Conference

DUBLIN, IRELAND: ...

Immunovaccine Announces Positive Interim Phase 1 Data for DepoVax(TM)-Based Respiratory Syncytial Virus Vaccine Candidate

HALIFAX, NOVA SCOTIA: Vaccine Demonstrated Tolerable Safety Profile, Induced Measurable Immunogenic Response in 100 Percent of Study Participants in Higher Dose Cohort Trial Provides Immunovaccine's First Clinical Imm ...

Theravance Biopharma Announces New Employment Inducement Awards

DUBLIN, IRELAND: ...

iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate

NEW YORK, NY: ...

Tiziana Life Sciences PLC: Result of AGM

LONDON, UNITED KINGDOM: ...

CORRECTION FROM SOURCE: Sernova Increases Private Placement to $4,200,000

LONDON, ONTARIO: ...

BioMmune, A 2016 TSX Venture Top 50 Company, Awarded Patent for Calcium Channel Monoclonal Antibodies

VANCOUVER, BRITISH COLUMBIA: ...

Sernova Increases Private Placement to $4,200,000

LONDON, ONTARIO: ...